Quarterly report pursuant to Section 13 or 15(d)

Shareholders??? Equity (Details Narrative)

v3.23.1
Shareholders’ Equity (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Aug. 26, 2022
Sep. 30, 2022
Mar. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Feb. 25, 2022
Dec. 31, 2021
Mar. 15, 2021
Jan. 28, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Common stock shares authorized   250,000,000   250,000,000     200,000,000    
Number of shares issued during the period   0   0          
Gross proceeds from common stock       $ 26,676,392        
Warrants outstanding   17,992,185   17,992,185          
Series A Preferred Stock [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Number of shares converted 4,000,000                
Series B Preferred Stock [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Number of shares converted 2,550,000                
Series C Preferred Stock [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Redemption of preferred stock, shares                 26.697
Redemption of preferred stock               $ 5,600,000  
Common Stock [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Common stock shares authorized   250,000,000   250,000,000   200,000,000      
Number of shares issued during conversion 910,003                
Number of shares issued during the period     23,871,338            
Warrants outstanding     2,472,573            
Gross proceeds from warrants     $ 2,300,000            
Common Stock [Member] | ATM Program [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Number of shares issued during the period     21,398,765            
Gross proceeds from common stock     $ 27,800,000